Morning Headlines 11/11/24

Doximity (DOCS) Tops Q2 Earnings and Revenue Estimates

Clinician network and drug marketing operator Doximity reports Q2 results: revenue up 20%, adjusted EPS $0.30 versus $0.22, beating expectations for both and sending DOCS shares up 34% in valuing the company at $11 billion.

McKesson, Oracle competing for Veradigm

McKesson, Oracle, and private equity firm Thoma Bravo are reportedly competing to acquire health IT, data, and analytics company Veradigm in a deal expected to close by Thanksgiving.

Waystar Reports Third Quarter 2024 Results

Waystar reports Q3 results: revenue up 22%, adjusted EPS $0.14 versus –$0.09, beating expectations for both.

Leidos awarded Organ Procurement and Transplantation Network operations contract

HHS awards Leidos a $235 million contract to modernize the country’s Organ Procurement and Transplant Network (OPTN).